<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04395573</url>
  </required_header>
  <id_info>
    <org_study_id>EESOA6</org_study_id>
    <nct_id>NCT04395573</nct_id>
  </id_info>
  <brief_title>Real Time 3D Navigation and Traditional US to Identify Epidural Space Depth in Obese Pregnant</brief_title>
  <acronym>Accuro</acronym>
  <official_title>Real Time 3D Navigation and Traditional US to Identify Epidural Space Depth in Obese Pregnant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European e-Learning School in Obstetric Anesthesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Milano Bicocca</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>European e-Learning School in Obstetric Anesthesia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the accuracy of the Accuro Ultrasound Device in estimating&#xD;
      the epidural space depth compared to the Standard Ultrasound Examination and with the&#xD;
      measured needle depth during epidural and spinal insertion in pregnant obese patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SpineNav3DTM technology facilitates image interpretation of individual 2D lumbar spine scans&#xD;
      by automating spinal bone landmark detection and depth measurements and providing a real-time&#xD;
      assessment of scan plane orientation in 3D.&#xD;
&#xD;
      All the subjects will have their lumbar area scanned for the measurements of the depth of the&#xD;
      epidural space (recorded in cm) by two blinded anesthesiologists, one using standard&#xD;
      ultrasounds and the other the Accuro Device.&#xD;
&#xD;
      All measurements will be performed either in the sitting or in the supine position at L1/L2,&#xD;
      L2/L3 and L3/L4 levels. Neuraxial anesthesia will be performed by using the previously marked&#xD;
      interspace by a blinded anesthesiologist who will measure the epidural space depth during&#xD;
      epidural or spinal insertion by marking the needle.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 30, 2021</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Epidural space depth</measure>
    <time_frame>up to 30 minutes</time_frame>
    <description>the depth of the epidural space (recorded in cm) is defined as the distance from the skin to the posterior complex</description>
  </primary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Obesity</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Accuro</intervention_name>
    <description>ultrasound device (Accuro, Rivanna Medical, Charlottesville, VA) with automated pattern recognition software programmed (SpineNav3DTM technology) to calculate the depth to epidural space and identify bony landmarks</description>
    <other_name>wireless portable ultrasound device</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard ultrasound device</intervention_name>
    <description>standard ultrasound device (o calculate the depth to epidural space and identify bony landmarks</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant Patients undergoing elective cesarean section or requesting labor epidural&#xD;
        analgesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA Status &gt;III&#xD;
&#xD;
          -  obese BMI&gt;30&#xD;
&#xD;
          -  term gestatio &gt; 37 weeks&#xD;
&#xD;
          -  singleton pregnancy&#xD;
&#xD;
          -  undergoing elective cesarean section with spinal anesthesia&#xD;
&#xD;
          -  requesting epidural labor analgesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contraindications to neuraxial block&#xD;
&#xD;
          -  severe scoliosis&#xD;
&#xD;
          -  previous spine surgery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant patients</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Giorgio Capogna, MD</last_name>
    <role>Study Director</role>
    <affiliation>European e-Learning School in Obstetric Anesthesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ASST S Gerardo</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Seligman KM, Weiniger CF, Carvalho B. The Accuracy of a Handheld Ultrasound Device for Neuraxial Depth and Landmark Assessment: A Prospective Cohort Trial. Anesth Analg. 2018 Jun;126(6):1995-1998. doi: 10.1213/ANE.0000000000002407.</citation>
    <PMID>28858898</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 14, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

